{"product_id":"community-acquired-pneumonia-isbn-9780470058091","title":"Community-Acquired Pneumonia","description":"\u003ci\u003eCommunity-Acquired Pneumonia (CAP)\u003c\/i\u003e refers to pneumonia acquired outside of hospitals or extended-care facilities, and is distinct from Nosocomial or hospital-acquired pneumonia, which is a separate disease entity. It is one of the most common respiratory infections and presents one of the major health problems today, with an incidence that ranges from eight to fifty cases per thousand individuals each year. Mortality is still very high and yet the risk factors are very well known. Many of these are related to antibiotic treatment; delay in administration, inadequacy of empiric antibiotics and lack of adherence to guidelines for treatment are all clearly associated with poor treatment outcomes.  \u003cp\u003eFollowing a description of the epidemiology and microbial etiology of ambulatory and hospitalized CAP, this book provides an in-depth review of the important new advances in therapeutics, including management of drug resistance to the three major classes of antibiotics used for treatment of CAP: β-lactams, macrolides and quinolones. All of them have advantages and disadvantages and these are put into perspective. This book highlights guideline recommendations and presents a balanced analysis to help physicians deliver the highest standard of care. In addition, the authors provide an insight into the 10% of patients who do not respond to antibiotics and could benefit from adjunctive therapies, some still under review.\u003c\/p\u003e \u003cp\u003eThis volume will be welcomed by pulmonologists and all clinicians involved in managing community-acquired pneumonia.  \u003c\/p\u003e  Preface  \u003cp\u003eList of Contributors\u003c\/p\u003e \u003cp\u003e1 Epidemiology of Community-Acquired Pneumonia Outside Hospital \u003ci\u003e(Theo JM Verheij)\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e2 Epidemiology of Adult Hospitalized Community-Acquired Pneumonia \u003ci\u003e(Mark Woodhead)\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e3 Microbial Aetiology and Antibiotic Resistances in\u003c\/p\u003e \u003cp\u003eCommunity-Acquired Pneumonia \u003ci\u003e(Gerard Huchon)\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e4 Microbiological Diagnosis of Community-Acquired Pneumonia \u003ci\u003e(Margareta Ieven)\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e5 Empirical Treatment of Community-Acquired Pneumonia: Current Guidelines \u003ci\u003e(Javier Aspa, Olga Rajas, Felipe Rodr´ıguez de Castro, Jos´e Blanquer and Antoni Torres)\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e6 Pathogen Directed Antimicrobial Treatment of Pneumonia \u003ci\u003e(Santiago Ewig and S¨oren Gatermann)\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e7 General Pharmacological Considerations in Antibiotic Treatment of Community-Acquired Pneumonia \u003ci\u003e(Francesco Blasi, Mario Cazzola and Paolo Tarsia)\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e8 β-Lactams in the Therapy of Community-Acquired Pneumonia \u003ci\u003e(Michael S. Niederman)\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e9 Macrolides and Ketolides \u003ci\u003e(Javier Garau)\u003cbr\u003e \u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e10 Role of Fluoroquinolones in the Treatment of Community-Acquired Pneumonia \u003ci\u003e(Tobias Welte)\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e11 Non-Responding Pneumonia \u003ci\u003e(Rosario Menendez)\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e12 Influenza and Pneumococcal Vaccination for Prevention of Community-Acquired Pneumonia in Immunocompetent Adults \u003ci\u003e(Ake Ortqvist)\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e13 Adjunctive Therapy in Community-Acquired Pneumonia \u003ci\u003e(Anna P. Lam and Richard G. Wunderink)\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eIndex\u003c\/p\u003e \u003cp\u003e\u003cb\u003eDr. Antoni Torres\u003c\/b\u003e, Cap de Servei de Pneumologia i Al'lèrgia Respiratria, Hospital Clínic de Barcelona, BARCELONA, SPAIN; Chairman, ERS Task Force on European Guidelines on hospital acquired pneumonia; Head, ERS Scientific Assembly on Respiratory Infections.\u003c\/p\u003e \u003cp\u003e\u003cb\u003eDr Rosario Menéndez\u003c\/b\u003e, Hospital Clínic de Barcelona, BARCELONA, SPAIN.\u003c\/p\u003e  \u003ci\u003eCommunity-Acquired Pneumonia (CAP)\u003c\/i\u003e refers to pneumonia acquired outside of hospitals or extended-care facilities, and is distinct from Nosocomial or hospital-acquired pneumonia, which is a separate disease entity. It is one of the most common respiratory infections and presents one of the major health problems today, with an incidence that ranges from eight to fifty cases per thousand individuals each year. Mortality is still very high and yet the risk factors are very well known. Many of these are related to antibiotic treatment; delay in administration, inadequacy of empiric antibiotics and lack of adherence to guidelines for treatment are all clearly associated with poor treatment outcomes.  \u003cp\u003eFollowing a description of the epidemiology and microbial etiology of ambulatory and hospitalized CAP, this book  provides an in-depth review of the important new advances in therapeutics, including management of drug resistance to the three major classes of antibiotics used for treatment of CAP: β-lactams, macrolides and quinolones. All of them have advantages and disadvantages and these are put into perspective. This book highlights guideline recommendations and presents a balanced analysis to help physicians deliver the highest standard of care. In addition, the authors provide an insight into the 10% of patients who do not respond to antibiotics and could benefit from adjunctive therapies, some still under review.\u003c\/p\u003e \u003cp\u003eThis volume will be welcomed by pulmonologists and all clinicians involved in managing community-acquired pneumonia.\u003c\/p\u003e","brand":"Wiley","offers":[{"title":"Default Title","offer_id":47988953841893,"sku":"NP9780470058091","price":223.95,"currency_code":"USD","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1842\/7735\/files\/9780470058091.jpg?v=1761782191","url":"https:\/\/k12savings.com\/products\/community-acquired-pneumonia-isbn-9780470058091","provider":"K12savings","version":"1.0","type":"link"}